286 related articles for article (PubMed ID: 24185941)
41. SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.
Dashti A; Waller C; Mavigner M; Schoof N; Bar KJ; Shaw GM; Vanderford TH; Liang S; Lifson JD; Dunham RM; Ferrari G; Tuyishime M; Lam CK; Nordstrom JL; Margolis DM; Silvestri G; Chahroudi A
J Virol; 2020 Oct; 94(21):. PubMed ID: 32817214
[TBL] [Abstract][Full Text] [Related]
42. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
[TBL] [Abstract][Full Text] [Related]
43. Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.
Julg B; Pereyra F; Buzón MJ; Piechocka-Trocha A; Clark MJ; Baker BM; Lian J; Miura T; Martinez-Picado J; Addo MM; Walker BD
Clin Infect Dis; 2010 Jul; 51(2):233-8. PubMed ID: 20550452
[TBL] [Abstract][Full Text] [Related]
44. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
[TBL] [Abstract][Full Text] [Related]
45. Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil.
Gomes STM; Gomes ÉR; Dos Santos MB; Lima SS; Queiroz MAF; Machado LFA; Cayres-Vallinoto IMV; Vallinoto ACR; de O Guimarães Ishak M; Ishak R
BMC Infect Dis; 2017 Jun; 17(1):381. PubMed ID: 28571570
[TBL] [Abstract][Full Text] [Related]
46. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
[TBL] [Abstract][Full Text] [Related]
47. HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood.
Hocini H; Bonnabau H; Lacabaratz C; Lefebvre C; Tisserand P; Foucat E; Lelièvre JD; Lambotte O; Saez-Cirion A; Versmisse P; Thiébaut R; Lévy Y
J Virol; 2019 May; 93(10):. PubMed ID: 30814287
[TBL] [Abstract][Full Text] [Related]
48. HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression.
Kammers K; Chen A; Monaco DR; Hudelson SE; Grant-McAuley W; Moore RD; Alter G; Deeks SG; Morrison CS; Eller LA; Blankson JN; Laeyendecker O; Ruczinski I; Eshleman SH; Larman HB
Front Immunol; 2021; 12():740395. PubMed ID: 34512672
[TBL] [Abstract][Full Text] [Related]
49. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Makutu DK; Nfanyana K; Rantleru T; Tierney A; Nkakana K; Schwartz AB; Gross R; Macgregor RR; Bellamy SL; Frank I; Weissman D; Bisson GP
J Infect Dis; 2013 Dec; 208(11):1784-93. PubMed ID: 23908475
[TBL] [Abstract][Full Text] [Related]
50. Elite and viremic HIV-1 controllers in West Africa.
N'takpé JB; Gabillard D; Moh R; Gardiennet E; Toni TD; Kouame GM; Badje A; Emieme A; Karcher S; Le Carrou J; Ménan H; Danel C; Eholie SP; Rouzioux C; Anglaret X; Lambotte O
AIDS; 2022 Jan; 36(1):29-38. PubMed ID: 34524145
[TBL] [Abstract][Full Text] [Related]
51. Plasmatic Levels of IL-18, IP-10, and Activated CD8
Côrtes FH; de Paula HHS; Bello G; Ribeiro-Alves M; de Azevedo SSD; Caetano DG; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
Front Immunol; 2018; 9():1576. PubMed ID: 30050532
[TBL] [Abstract][Full Text] [Related]
52. Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.
Papasavvas E; Pistilli M; Reynolds G; Bucki R; Azzoni L; Chehimi J; Janmey PA; DiNubile MJ; Ondercin J; Kostman JR; Mounzer KC; Montaner LJ
AIDS; 2009 Jan; 23(3):369-75. PubMed ID: 19114856
[TBL] [Abstract][Full Text] [Related]
53. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.
Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR
J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843
[TBL] [Abstract][Full Text] [Related]
54. Short communication: Plasmacytoid dendritic cells from HIV-1 Elite Controllers maintain a gut-homing phenotype associated with immune activation.
Li H; Goepfert P; Reeves RK
AIDS Res Hum Retroviruses; 2014 Dec; 30(12):1213-5. PubMed ID: 25387330
[TBL] [Abstract][Full Text] [Related]
55. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.
Sereti I; Estes JD; Thompson WL; Morcock DR; Fischl MA; Croughs T; Beq S; Lafaye de Micheaux S; Yao MD; Ober A; Wilson EM; Natarajan V; Imamichi H; Boulassel MR; Lederman MM; Routy JP
PLoS Pathog; 2014 Jan; 10(1):e1003890. PubMed ID: 24497828
[TBL] [Abstract][Full Text] [Related]
56. Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load.
Malhotra P; Haslett P; Sherry B; Shepp DH; Barber P; Abshier J; Roy U; Schmidtmayerova H
Sci Rep; 2019 Apr; 9(1):5963. PubMed ID: 30979916
[TBL] [Abstract][Full Text] [Related]
57. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
[TBL] [Abstract][Full Text] [Related]
58. Higher SLPI expression, lower immune activation, and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers.
Taborda NA; Cataño JC; Delgado JC; Rugeles MT; Montoya CJ
J Acquir Immune Defic Syndr; 2012 May; 60(1):12-9. PubMed ID: 22240462
[TBL] [Abstract][Full Text] [Related]
59. Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1-Infected West African Adults With High CD4 Counts.
Affi R; Gabillard D; Dunyach-Remy C; Ntakpe JB; Moh R; Badje A; Kouame GM; Karcher S; Le Carrou J; Danel C; Chevalier MF; Rouzioux C; Eholie SP; Lavigne JP; Inwoley A; Anglaret X; Weiss L
J Acquir Immune Defic Syndr; 2021 Jan; 86(1):138-145. PubMed ID: 33074857
[TBL] [Abstract][Full Text] [Related]
60. Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers.
Picton ACP; Paximadis M; Koor GW; Bharuthram A; Shalekoff S; Lassauniere R; Ive P; Tiemessen CT
Front Immunol; 2021; 12():781263. PubMed ID: 34987508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]